123 related articles for article (PubMed ID: 7690212)
1. On the role of costimulation in tumor immunity.
Hellström KE; Hellström I; Linsley P; Chen L
Ann N Y Acad Sci; 1993 Aug; 690():225-30. PubMed ID: 7690212
[No Abstract] [Full Text] [Related]
2. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
Harding FA; Allison JP
J Exp Med; 1993 Jun; 177(6):1791-6. PubMed ID: 7684435
[TBL] [Abstract][Full Text] [Related]
3. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.
Chen L; Ashe S; Brady WA; Hellström I; Hellström KE; Ledbetter JA; McGowan P; Linsley PS
Cell; 1992 Dec; 71(7):1093-102. PubMed ID: 1335364
[TBL] [Abstract][Full Text] [Related]
4. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of B7/BB1 on activated T lymphocytes.
Azuma M; Yssel H; Phillips JH; Spits H; Lanier LL
J Exp Med; 1993 Mar; 177(3):845-50. PubMed ID: 7679711
[TBL] [Abstract][Full Text] [Related]
6. Modulation of costimulation to enhance tumor immunity.
Vesosky B; Hurwitz AA
Cancer Immunol Immunother; 2003 Nov; 52(11):663-9. PubMed ID: 12920481
[No Abstract] [Full Text] [Related]
7. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
8. Role of CD4 and CD8 in enhancing T-cell responses to antigen.
Parnes JR; von Hoegen P; Miceli MC; Zamoyska R
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():649-55. PubMed ID: 2518008
[No Abstract] [Full Text] [Related]
9. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
10. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley PS; Clark EA; Ledbetter JA
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5031-5. PubMed ID: 2164219
[TBL] [Abstract][Full Text] [Related]
11. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475
[TBL] [Abstract][Full Text] [Related]
12. Costimulatory approaches to adoptive immunotherapy.
Liebowitz DN; Lee KP; June CH
Curr Opin Oncol; 1998 Nov; 10(6):533-41. PubMed ID: 9818232
[TBL] [Abstract][Full Text] [Related]
13. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
14. CD28-B7 interactions are not required for intrathymic clonal deletion.
Jones LA; Izon DJ; Nieland JD; Linsley PS; Kruisbeek AM
Int Immunol; 1993 May; 5(5):503-12. PubMed ID: 7686392
[TBL] [Abstract][Full Text] [Related]
15. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L; Clark EA; Shu G; Dupont B
J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
[TBL] [Abstract][Full Text] [Related]
16. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
Ramarathinam L; Castle M; Wu Y; Liu Y
J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683
[TBL] [Abstract][Full Text] [Related]
17. The biology of human CD2.
Reinherz EL; Chang HC; Clayton LK; Gardner P; Howard FD; Koyasu S; Jin YJ; Moingeon P; Sayre PH
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():611-25. PubMed ID: 2577023
[No Abstract] [Full Text] [Related]
18. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
19. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
[TBL] [Abstract][Full Text] [Related]
20. B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice.
Hazlett LD; McClellan S; Barrett R; Rudner X
J Immunol; 2001 Jan; 166(2):1292-9. PubMed ID: 11145712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
